Abstract:Commercial heparin production, a widely applied anticoagulant, requires a series of time-consuming and costly separation units to achieve isolation and purification and the challenging removal of macromolecular impurities, such as proteins. We report a novel separation strategy for the first time that can capture heparin while simultaneously recovering proteins through an efficient one-step separation. Novel adsorptive membranes were prepared by grafting polymer brushes of (3-acrylamidopropyl) trimethylammonium chloride (APTMAC) onto the surface of poly(vinylidene fluoride) (PVDF) membrane via atom transfer radical polymerization (ATRP) by controlling the polymerization time. The prepared membrane exhibited excellent hydrophilicity with water contact angle of 26.57° and adsorption capacity for heparin (598.6 μg/cm 2 ). XPS, FTIR measure and density functional theory (DFT) simulation demonstrated that the adsorptive membrane could effectively adsorb heparin on the surface via the electrostatic interaction between -N(CH 3 ) 3 + groups of the grafted APTMAC on the membranes and the reactive functional groups (OSO 3 − , NHSO 3 − , COO − ) of heparin. Membrane filtration results showed that the adsorptive membranes created one-step separations that could selectively capture heparin via electrostatic interaction while rejecting and concentrating bovine serum albumin (BSA) because of size sieving and hydrated layer repulsion. Besides, the purity of crude heparin increased from 60 % to 93 % through using adsorptive membrane filtration. Moreover, the heparin adsorption capacity remained at 82.3 % of its original capacity after six cycles. This study provides a novel strategy for efficient, economic and selective multi-functional separations for heparin and its similar biomedical medicines.

From Farm to Pharma: An Overview of Industrial Heparin Manufacturing Methods

Synthesis of bioengineered heparin chemically and biologically similar to porcine-derived products and convertible to low MW heparin

Bioengineered heparin: Advances in production technology

Production, characteristics and applications of microbial heparinases

A Unique Enoxaparin Derived from Bovine Intestinal Heparin: A Single Purification Step of the Starting Material Assures a Bovine Enoxaparin Like the Standard from Porcine Origin

Chemobiocatalytic Synthesis of a Low-Molecular-Weight Heparin

Highly efficient one-step selective separation of heparin via multi-functional adsorptive membranes

Preparation of Low Molecular Weight Heparin Using an Ultrasound-Assisted Fenton-system

Preparation of Low Molecular Weight Heparin from a Remodeled Bovine Intestinal Heparin

High-Level Expression and Purification of Recombinant Heparinase Ⅰ in Escherichia Coli

Pharmacology of Heparin and Related Drugs

Biosynthetic production of anticoagulant heparin polysaccharides through metabolic and sulfotransferases engineering strategies

Progress in the Study of Heparinases

Enzymatic access to the rare ΔUA (1→4) Glc 3, 6, N-sulfated heparin disaccharide, implications for heparin quality control

The US regulatory and pharmacopeia response to the global heparin contamination crisis

Development of effective heparin extraction method from pig by-products and analysis of their bioavailability

Comparison Of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin

The heparin recall of 2008

E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor

Enzymatic synthesis of low molecular weight heparins from N-sulfo heparosan depolymerized by heparanase or heparin lyase

Heparinase Digestion-based Disaccharide Analysis of Clinical Heparin and Heparinoids Drug